Wikipedia

Gedela Srinubabu

Gedela Srinubabu is the chief executive officer of Pulsus Group.[3] He founded the OMICS Publishing Group publishing group, scientific journal publishing company that publishes science findings online for free.[4]

Gedela Srinubabu
Gedela Srinubabu in 2019, Indian Delegation to Europe
Born
Allena, Srikakulam, India
Alma materB.Pharma, MTech, PhD at Andhra University, and Post Doctorate at Stanford University
Occupation(s)Scientist, industrialist
Employer(s)CEO, Pulsus Group
TitleVice-President of Federation of Asian Biotech Association (FABA) and Delegation of India to the European Union[1][2]
Websitehttp://www.srinubabu.com

Srinubabu served as the co-convenor of the Health, Pharma, and Tech Summit Series, executed across G20 countries to promote AI in healthcare and technology advancements.[5][6] He is also serving as BC Leader, participated in farmer empowerment programs and also serving as executive council member of Dr Ambedkar University. [7][8][9]

However, OMICS journals and other journals, conferences have been characterized as predatory publishing journals and predatory conferences with poor quality controls and a lack of legitimate services[10][11][12] As a result of this business model, Srinubabu's journals have been banned from indexing within the National Institutes of Health's PubMed Central.[13] Additionally, in 2019, his company OMICS Publishing Group[14] was required to pay 50.1 million dollars in damages[15] following a US Federal Trade Commission complaint that the company was deceiving researchers[16] and the academicians.[17][18]

Biography

Srinubabu completed his PhD from Andhra University and his post-doctorate from Stanford University. In 2007, he received the Young Scientist Award from the Human Proteome Organization in Seoul, South Korea.[19][13][20]

Srinubabu has published research articles on how to study biological phenomena using mathematical models and how to detect cancer or diabetes early. He has published about 30 articles in various peer-reviewed journals. According to Google Scholar, Srinubabu's articles have been cited about 580 times, giving him an h-index of 13.[21]

Scientific publishing

Srinubabu founded the notorious open-access publisher, OMICS Publishing Group, widely regarded as predatory. He purchased Pulsus Group in 2016, causing controversy and putting the future of the journals that it published into question.[12] The company has been placed on Jeffrey Beall's list of "Potential, possible, or probable" predatory open-access publishers.[22]

FABA Vice-President

 
Gedela Srinubabu as FABA Vice President for China-India Bilateral

In 2013, Srinubabu served as the Vice President of the Federation of Asian Biotech Association (FABA) to improve the global trade, BS Bajaj said that the representation and services of Gedela is crucial in increasing FABA's global growth.[1][23] In 2019, Srinubabu worked for Bilateral investment treaty of India and China.[24][25]

Europe-India trade delegation

Belgium Embassy delegates and European delegation team visited the Pulsus Group office in Hyderabad in 2018 to sign an agreement to establish a Pulsus center in Belgium.[26] At the 2019 Thessaloniki International Fair (TIF) held in Greece, Srinubabu along with Indian Union Minister Hardeep Singh Puri participated as Indian delegation and met with the Prime Minister of Greece, Kyriakos Mitsotakis to discuss the translation of health care and agriculture information into regional languages.[2][27][28]

Legal and regulatory affairs

 
Gedela Srinubabu - Indo American Chamber of Commerce 2022

Since 2013, US-based blogger Jeffrey Beall has used his personal blog, scholarlyoa.com, to criticise the publishing practises of Omics Group and Srinubabu. Through his blog, allegations were made against Omics regarding the quality of its scientific journals and its business practises.[29][30] Omics files a lawsuit against Jeffrey Beall, seeking damages of $1 billion.[31] Effective January 2017, Jeffrey Beall resigned from his services at University of Colorado Denver and shut his blogs. However, no further follow-up was made about damages of $1 billion in legal affairs.[32]

In 2016, based on blog postings by Beall, the Trade Commission of the United States filed a lawsuit against Omics publishing practices, citing their detrimental effects on American publisher's loss of trade to the United States. If 10,000 articles article is published in open access journals, the publication cost is about $10 million with an average $2000 article processing cost, depending on the open-access journal publisher's model, and if the same 10,000 articles are published under a subscription business, they can generate about $500 million annually by giving subscriptions to thousands of universities and research institutions across the world. Subscription models are followed by the majority of Western publishing companies, including academic publishing companies of United States.[33][34] In April 2019, the court imposed a fine of US$50.1 Million on Omics companies.[35][36][37] Omics' lawyer said that this was an unfair allegation and that Omics had sued the US Federal Trade Commission for $3.11 billion in damages, saying it had caused loss of revenue and reputation.[36][38] Srinubabu commented on the case filed by the Federal Trade Commission. "The Federal Trade Commission's allegation is completely wrong... They don't know what a journal is. Don't know what peer review is. They are illiterate in this matter. But scientists are not illiterate, they know which article to publish in which journal."[38]

In politics

The party announced Srinubabu as the Jana Sena candidate for the Visakhapatnam parliamentary constituency in the 2019 general elections [39] But after two or three days, Srinubabu left the party and joined the YSR Congress party.[40]

Philanthropic activities

In 2018 Srinubabu visited areas affected by Cyclone Titli and observed distribution of food, blankets and clothing.[41][42][43] His organization has donated one crore rupees to Government of Andhra Pradesh, twenty five lakh rupees to Government of Telangana and distributed masks and sanitizers in various districts for the relief of coronavirus during the COVID-19 pandemic in India,[44][45] and also donated Rs 20 lakhs to Ram Mandir construction.[46]

Awards

 
Dr Srinubabu Gedela Champions of Change Award from Vice President of India

Srinubabu received the Pride of the Nation Award in 2019,[47] and the Government of India Champions of Change 2018 award.[48]

Andhra Premier League Vizag Warriors

Srinubabu is the owner of Vizag Warriors, of the Andhra Premier League T20 cricket league in Andhra Pradesh.[49][50][51]

Indian actor, producer and businessman Ram Charan has invested in the team with Srinubabu, aiming to get the team promoted to the IPL in 2024.[52][53]

References

  1. ^ a b "Asian biotech body Vice-President". thehindubusinessline.com. 14 October 2013.
  2. ^ a b "Dr. Srinubabu to Represent STPI Telangana and AP at Thessaloniki's International Fair (TIF) in Greece". The Hans India. 3 September 2019.
  3. ^ Basu, Arpit M. (1 January 2021). "Smaller tech firms homing in on Visakhapatnam". The Times of India.
  4. ^ "Pulsus opens healthcare informatics, pharmacovigilance facility in Chennai". The Times of India. 9 March 2018.
  5. ^ "'India will become AI -Powered manufacturing hub'". The Times of India. 8 November 2023. Retrieved 15 December 2023.
  6. ^ Bureau, The Hindu (16 December 2022). "Global Tech team to promote the G20-Summit from January". The Hindu. Retrieved 15 December 2023.
  7. ^ "Ambedkar University, Pulsus Group to conduct skill training programmes". The Hindu. 3 November 2023.
  8. ^ "Focus on Creating Agri-based Jobs: Pulsus Group". Deccan Chronicle. 30 December 2023.
  9. ^ K, Srinivasa Rao (3 November 2023). "Need for economic corridors in Vizianagaram district stressed". The Hindu.
  10. ^ Patnaik, Santosh (26 September 2012). "Chanting success mantra, scientific way". The Hindu. Archived from the original on 12 April 2021. Retrieved 30 October 2019.{{cite news}}: CS1 maint: bot: original URL status unknown (link)
  11. ^ "Scientific publisher Omics scripts major expansion; plans ₹1,000-cr investment". The Hindu. 16 January 2018. Retrieved 18 March 2022.
  12. ^ a b Deprez, Esmé E.; Chen, Caroline (29 August 2017). "Medical Journals Have a Fake News Problem". Bloomberg News. Archived from the original on 25 January 2019.
  13. ^ a b Roberts, William Clifford (1 February 2018). "Facts and ideas from anywhere". Baylor University. Vol. 31, no. 1. pp. 141–151. doi:10.1080/08998280.2017.1401850. PMC 5903519. PMID 29686586.
  14. ^ "FTC Charges Academic Journal Publisher OMICS Group Deceived Researchers". Federal Trade Commission. 26 August 2016. Retrieved 11 October 2023.
  15. ^ Prasad, R. (3 April 2019). "Hyderabad-based OMICS fined $50 million for 'unfair, deceptive business practices'". The Hindu. ISSN 0971-751X. Retrieved 11 October 2023.
  16. ^ "US court fines journal publisher USD 50 million for 'deceptive practices'". The Indian Express. 5 April 2019. Retrieved 11 October 2023.
  17. ^ "Cases and Proceedings - OMICS Group Inc". Federal Trade Commission. 26 August 2016.
  18. ^ "Hyderabad-Based OMICS Fined $50 Million for 'Deceptive Practices'". The Wire. Retrieved 11 October 2023.
  19. ^ "Selected for award". The Hindu. 4 October 2007.
  20. ^ Patnaik, Santosh (26 September 2012). "Chanting success mantra, scientific way". The Hindu. Archived from the original on 12 April 2021. Retrieved 30 October 2019.
  21. ^ "Srinubabu Gedela Stanford University". Google Scholar. 25 May 2023.
  22. ^ Beall, Jeffrey. "LIST OF PUBLISHERS". Scholarly Open Access. Archived from the original on 17 September 2016. Retrieved 21 September 2016.
  23. ^ "Three Global Conferences "Agri-2014", "Biosimilars 2014" and "Pharmacovigilance-2014" kicked off in city today". www.apnnews.com. 28 October 2014.
  24. ^ "Srinubabu Gedela is FABA vice president". www.biospectrumasia.com. 13 October 2013.
  25. ^ "srinubabu gedela opinion if india ban china products". www.sakshi.com. 14 July 2020.
  26. ^ "Pulsus to expand scientific research, publications to Europe". Economic Times. 25 April 2018.
  27. ^ "Pulsus to expand scientific research, publications to Europe". economictimes.indiatimes.com. 25 April 2018.
  28. ^ "Dr. Srinubabu to represent STPI Telangana, AP at TIF in Greece". www.siasat.com. 5 September 2019.
  29. ^ Beall, Jeffrey; Levine, Richard (25 January 2013). "OMICS Goes from "Predatory Publishing" to "Predatory Meetings"". Scholarly Open Access. Archived from the original on 5 June 2016. Retrieved 22 October 2016.
  30. ^ "The OMICS Publishing Group's Empire is Expanding". scholarlyoa.co. 22 July 2013. Archived from the original on 19 October 2023. Retrieved 21 May 2023.
  31. ^ "Publishing firm in $1 bn libel row with US blogger". www.hindustantimes.com. 18 May 2013.
  32. ^ Silver, Andrew (18 May 2013). "Controversial website that lists 'predatory' publishers shuts down". Nature. doi:10.1038/nature.2017.21328. S2CID 157913572.
  33. ^ "Full statement by Srinubabu Gedela, CEO and Managing Director of OMICS Group". www.ctvnews.ca. 28 September 2016.
  34. ^ "Bloomberg Businessweek Feature Medical Journals Have a Fake News Problem". www.bloomberg.com. 29 August 2017.
  35. ^ "OMICS Group Inc". ఫెడరల్ ట్రేడ్ కమిషను. 26 August 2016. Archived from the original on 23 March 2022. Retrieved 23 March 2022.
  36. ^ a b Prasad, R. (3 April 2019). "Hyderabad-based OMICS fined $50 million for 'unfair, deceptive business practices'". The Hindu. ISSN 0971-751X. Archived from the original on 23 March 2022. Retrieved 23 March 2022.
  37. ^ "BRIEF OF THE FEDERAL TRADE COMMISSION" (PDF). www.ftc.gov. 11 October 2011. Archived from the original (PDF) on 4 November 2021. Retrieved 4 November 2021.
  38. ^ a b Yadav, Shamlal (20 July 2018). "OMICS chief Srinubabu Gedela: 'Our revenue from India is almost zero'". The Indian Express.
  39. ^ "32 మంది అభ్యర్థులతో జనసేన తొలి జాబితా!". andhrapradesh.suryaa.com. Archived from the original on 23 March 2022. Retrieved 23 March 2022.
  40. ^ "జనసేనకు మరో షాక్". ఆంధ్రజ్యోతి. 16 March 2019. Archived from the original on 23 March 2022. Retrieved 23 March 2022.
  41. ^ "Dr. Srinubabu Gedela receives 'Champions of Change' Award from Vice President of India". 27 December 2018.
  42. ^ "శ్రీకాకుళం జిల్లా టైటిలి తుఫాన్ బాధిత కుటుంబాలకు పల్సస్ అధినేత గెడలా శ్రీనుబాబు". YouTube. 19 November 2018.
  43. ^ "Hyderabad scientist receives 'Champions of Change' Award". The Times of India. 31 December 2018.
  44. ^ "సీఎం సహాయనిధికి విరాళాల వెల్లువ". 19 May 2020.
  45. ^ "Coronavirus: Donations continue to pour in to Telangana CM relief fund, citizens hand over cheques to CM K Chandrashekhar Rao". 14 April 2020.
  46. ^ "Rs 10 lakh donated to Ayodhya Ram temple". 15 February 2021.
  47. ^ "Pulsus CEO, Dr. Srinubabu Gedela received Pride of the Nation Award". The Hans India. 22 July 2019.
  48. ^ "పల్సస్‌ ఎండీ శ్రీనుబాబుకు అవార్డు". Sakshi. 27 December 2018.
  49. ^ "Chief Minister unveils logo of 'Vizag Warriors' in Visakhapatnam". The Hindu. 13 May 2023. Retrieved 13 May 2023.
  50. ^ "The CM also launched the Andhra Premier League Season – 2". Outlook. 12 May 2023. Retrieved 13 May 2023.
  51. ^ "ACA announces Andhra Premier League season 2". The Hindu. 7 May 2023. Retrieved 13 May 2023.
  52. ^ "Ram Charan: Ram Charan is buying a cricket team.. not in IPL!". theglobalfrontier.com. 6 May 2023. Retrieved 13 May 2023.
  53. ^ "RRR Star Ram Charan's Next Target An IPL Team". Network18 Group. 6 May 2023.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Gedela_Srinubabu&oldid=1214913094"